Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005696 |
XU_ID: | XU-552 |
ID: | TCMBANKHE005696/XU-552 |
植物拉丁名: |
|
功能与主治: | To diffuse lung qi, dispel wind-damp, disperse swelling toxin./Cough and shortness of breath, wind-damp impediment pain, itchy skin, innominate toxin swelling. |
药用植物名: | 骆驼蓬 |
来源: | 甘肃省定西市岷县 |
药用部位: | whole herb|全株 |
KUMST_ID1: | KMUST-BS-0565 |
KUMST_ID2: | KMUST-20240411000104-1 |
TCM_ID_id: | 1659 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN006173 | derriscanoside a | C28H32O13 | 576.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC4=C(C=C3)C(=O)C(=CO4)C5=CC=C(C=C5)OC)O)O)O)O)O)O | |
| TCMBANKIN013916 | Deoxyvasicinone | Pyrrolo(2,1-b)quinazolin-9(1H)-one, 2,3-dihydro-; 1,2,3,10-tetrahydro-pyrrolo[2,1-b]quinazolin-9-one; AC1Q1HJF; BG00602365; BBL028460; InChI=1/C11H10N2O/c14-11-8-4-1-2-5-9(8)12-10-6-3-7-13(10)11/h1-2,4-5H,3,6-7H; AC1Q6FYI; ST50135008; 1H,2H,3H,9H-pyrrolo[2,1-b]quinazolin-9-one; SCHEMBL864139; 4-hydropyrrolidino[2,1-b]quinazolin-5-one; AKOS002210198; VARHXCYGZKSOOO-UHFFFAOYSA-N; DTXSID90201049; deoxyvasicinone; W1018; STOCK1N-00997; cid_68261; Pyrrolo[2,1-b]quinazolin-9(1H)-one, 2,3-dihydro-; MolPort-000-489-741; CHEBI:4435; 3H-Quinazolin-4-one, 2,3-trimethyleno; FCH831074; SR-01000434191; 2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one\n2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one\n2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one; BDBM50244216; SMR000024071; HMS2507B03; MLS000088451; MFCD00247051; STL373117; ZINC226366; NSC 159478; AC1L29DJ; BB_NC-02943; SR-01000434191-1; CHEMBL456881; NSC159478; ZINC00226366; 4CN-1561; MCULE-8877508828; NSC-159478; 530-53-0; BB_NC-1382; C10659; 2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one; Pyrrolo[2,1-b]quinazolin-9(1H)-one,2,3-dihydro-; Desoxyvasicinon; 2,3-Trimethylene-4-quinazolone; 2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one | C11H10N2O | 186.21 | C1CC2=NC3=CC=CC=C3C(=O)N2C1 |
| TCMBANKIN018900 | rupestonic acid | rupestonicacid | C15H20O3 | 248.32 g/mol | CC1CCC(CC2=C(C(=O)CC12)C)C(=C)C(=O)O |
| TCMBANKIN020016 | pegamine | peg-amine; 2-(3-hydroxypropyl)-1H-quinazolin-4-one; Pegamine; 2-(3-hydroxypropyl)quinazolin-4(1H)-one; 31431-93-3; 2-(3-Hydroxypropyl)-4(3H)-quinazolinone; AC1O3DSY; 4(3H)-Quinazolinone, 2-(3-hydroxypropyl)- | C11H12N2O2 | 204.22 g/mol | C1=CC=C2C(=C1)C(=O)NC(=N2)CCCO |
| TCMBANKIN021138 | vasicinone | C11H10N2O2 | 202.21 g/mol | C1CN2C(=NC3=CC=CC=C3C2=O)C1O | |
| TCMBANKIN022596 | peganol | C11H12N2O | 188.23 g/mol | C1CC2=NC3=CC=CC=C3C(N2C1)O | |
| TCMBANKIN026276 | harmaline | C13H14N2O | 214.26 | CC1=NCCC2=C1NC3=C2C=CC(=C3)OC | |
| TCMBANKIN029060 | ruine | 32472-23-4; Ruine | C19H22N2O7 | 390.4 g/mol | CC1=NC=CC2=C1NC3=C2C=CC(=C3OC4C(C(C(C(O4)CO)O)O)O)OC |
| TCMBANKIN032476 | vasicoline | C19H21N3 | 291.4 g/mol | CN(C)C1=CC=CC=C1C2CCN3C2=NC4=CC=CC=C4C3 | |
| TCMBANKIN035569 | harmalol | C12H12N2O | 200.24 | CC1=NCCC2=C1NC3=C2C=CC(=C3)O | |
| TCMBANKIN035964 | harmol | C12H10N2O | 198.22 g/mol | CC1=C2C(=C3C=CC(=O)C=C3N2)C=CN1 | |
| TCMBANKIN036704 | vasicinol | C11H12N2O2 | 204.22 g/mol | C1CN2CC3=C(C=CC(=C3)O)N=C2C1O | |
| TCMBANKIN037796 | peganidine | C14H16N2O2 | |||
| TCMBANKIN038086 | pedunculoside | Pedunculoside; 42719-32-4; BG01194158; Y0154; CHEMBL508539; MolPort-027-720-897; ZINC49899431; C36H58O10; MFCD01632712; N2574; (2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL (1R,2R,4AS,6AS,6BR,8AR,9R,10S,12AR,12BR,14BS)-1,10-DIHYDROXY-9-(HYDROXYMETHYL)-1,2,6A,6B,9,12A-HEXAMETHYL-2,3,4,5,6,7,8,8A,10,11,12,12B,13,14B-TETRADECAHYDROPICENE-4A-CARBOXYLATE | C36H58O10 | 650.84 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1(C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O |
| TCMBANKIN042909 | peganidin | C16H13O7+ | 244.289 | COC1=CC(=CC(=C1O)O)C2=C(C=C3C(=CC(=CC3=[O+]2)O)O)O | |
| TCMBANKIN058591 | Deoxypeganin | Spectrum3_001158; BSPBio_002715; Spectrum5_000927; 1,2,3,9-Tetrahydro-pyrrolo[2,1-b]quinazoline; KBioGR_002479; 3-Deoxyvasicine; SPBio_001620; C10656; SDCCGMLS-0066767.P001; KBio3_002215; Deoxypeganine; 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline; Desoxypeganine; 3-Deoxypeganine; Spectrum4_001977; Spectrum2_001690; BAS 00867603; ZINC00265524; Pyrrolo(2,1-b)quinazoline, 1,2,3,9-tetrahydro-; BB_NC-0767;AB00830873-05; MCULE-1061961665; Spectrum5_000927; 1,2,3,9-Tetrahydro-pyrrolo[2,1-b]quinazoline; ZX-AN036960; Desoxypeganine, HF Arzneimittelforschung; STOCK1N-10458; BBL010599; DTXSID40197807; Deoxypeganin; BRD-K13819402-003-02-9; KBioGR_002479; 3-Deoxyvasicine; ALBB-021365; SPBio_001620; 4,5-dihydropyrrolidino[2,1-b]quinazoline; SCHEMBL3387188; C10656; ST092796; AB00830873-04; SDCCGMLS-0066767.P001; AC1L9DLE; STK801663; HMS1672N18; SR-01000783332; KBio3_002215; Deoxypeganine; BDBM50289102; 61939-05-7 (hydrochloride); 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline; D0T5AW; FCH834788; EN300-186641; ZINC265524; pyrrolo[2,1-b]quinazoline, 1,2,3,9-tetrahydro-, hydrochloride; Desoxypeganine; 3-Deoxypeganine; AKOS000591523; Spectrum4_001977; SR-01000783332-4; Spectrum2_001690; CHEBI:4428; BAS 00867603; 495-59-0; CHEMBL355821; Alcoholism therapy, HF Arzneimittelforschung; Pyrrolo(2,1-b)quinazoline, 1,2,3,9-tetrahydro-; MolPort-001-949-689;deoxypeganine | C11H12N2 | 172.23 g/mol | C1CC2=NC3=CC=CC=C3CN2C1 |
| TCMBANKIN058633 | peganine | vasicine | C11H12N2O | 188.23 | C1CN2CC3=CC=CC=C3N=C2C1O |
| TCMBANKIN060060 | harmine | C13H12N2O | 212.25 | CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC | |
| TCMBANKIN060556 | peduneuloside | C36H58O10 | 650.84 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1(C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O | |
| TCMBANKIN060582 | Verticine | C27H45NO3 | 431.7 g/mol | CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(C6C5(CCC(C6)O)C)O)(C)O | |
| TCMBANKIN061781 | hernandin | 69222-20-4 (UNSPECIFIED); AIDS006791; Deoxypodophyllotoxin; AIDS-006791; (5aR,8aR,9R)-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofurano[5,6-f][1,3]benzodioxol-8-one; (-)-Deoxypodophyllotoxin; (-)-Anthricin; Hernandin; Anthricin; DPT; Podophyllotoxin, deoxy-; SILICICOLIN; Desoxypodophyllotoxin; Anthriscin; NCI60_003794; (-)-Desoxypodophyllotoxin; 19186-35-7; 19186-35-7 (5R,5AR,8AR); Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-5-(3,4,5-trimethoxyphenyl)-,(5R,5aR,8aR)-; 5,8,8a,9,-Tetrahydro-5-(3,4,5-trimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; NSC403148; Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 5,8,8a,9-tetrahydro-5-(3,4,5-trimethoxyphenyl)-, (5R,5aR,8aR)-; C10556; 4-Deoxypodophyllotoxin; deoxypodophyllotoxin; (-)-deoxypodophyllotoxin; anthricin isomer; isoanthricin; anthricin | C22H22O7 | 398.4 g/mol | COC1=CC(=CC(=C1OC)OC)C2C3C(CC4=CC5=C(C=C24)OCO5)COC3=O |
| TCMBANKIN000901 | tetrahydroharmine | (R)-Tetrahydroharmine; (+)-Tetrahydroharmine; UNII-F1Q1E0G45A component ZXLDQJLIBNPEFJ-MRVPVSSYSA-N; 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-7-methoxy-1-methyl-, (1R)-; 7759-46-8; ZINC2112084; AC1L9CA2; (1r)-tetrahydroharmine; AF812R7053; UNII-AF812R7053; CHEBI:9485; 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-7-methoxy-1-methyl-, (R)-; (1R)-7-methoxy-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole; C09243; 1H-Pyrido(3,4-b)indole, 2,3,4,9-tetrahydro-7-methoxy-1-methyl-, (+)- | C13H16N2O | 216.28 g/mol | CC1C2=C(CCN1)C3=C(N2)C=C(C=C3)OC |
| TCMBANKIN006173 | derriscanoside a | C28H32O13 | 576.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC4=C(C=C3)C(=O)C(=CO4)C5=CC=C(C=C5)OC)O)O)O)O)O)O | |
| TCMBANKIN013916 | Deoxyvasicinone | Pyrrolo(2,1-b)quinazolin-9(1H)-one, 2,3-dihydro-; 1,2,3,10-tetrahydro-pyrrolo[2,1-b]quinazolin-9-one; AC1Q1HJF; BG00602365; BBL028460; InChI=1/C11H10N2O/c14-11-8-4-1-2-5-9(8)12-10-6-3-7-13(10)11/h1-2,4-5H,3,6-7H; AC1Q6FYI; ST50135008; 1H,2H,3H,9H-pyrrolo[2,1-b]quinazolin-9-one; SCHEMBL864139; 4-hydropyrrolidino[2,1-b]quinazolin-5-one; AKOS002210198; VARHXCYGZKSOOO-UHFFFAOYSA-N; DTXSID90201049; deoxyvasicinone; W1018; STOCK1N-00997; cid_68261; Pyrrolo[2,1-b]quinazolin-9(1H)-one, 2,3-dihydro-; MolPort-000-489-741; CHEBI:4435; 3H-Quinazolin-4-one, 2,3-trimethyleno; FCH831074; SR-01000434191; 2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one\n2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one\n2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one; BDBM50244216; SMR000024071; HMS2507B03; MLS000088451; MFCD00247051; STL373117; ZINC226366; NSC 159478; AC1L29DJ; BB_NC-02943; SR-01000434191-1; CHEMBL456881; NSC159478; ZINC00226366; 4CN-1561; MCULE-8877508828; NSC-159478; 530-53-0; BB_NC-1382; C10659; 2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one; Pyrrolo[2,1-b]quinazolin-9(1H)-one,2,3-dihydro-; Desoxyvasicinon; 2,3-Trimethylene-4-quinazolone; 2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one | C11H10N2O | 186.21 | C1CC2=NC3=CC=CC=C3C(=O)N2C1 |
| TCMBANKIN019623 | harpagide acetate | harpagideacetate | 406.43 | CC(=O)OCC1CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O | |
| TCMBANKIN021138 | vasicinone | C11H10N2O2 | 202.21 g/mol | C1CN2C(=NC3=CC=CC=C3C2=O)C1O | |
| TCMBANKIN022596 | peganol | C11H12N2O | 188.23 g/mol | C1CC2=NC3=CC=CC=C3C(N2C1)O | |
| TCMBANKIN026276 | harmaline | C13H14N2O | 214.26 | CC1=NCCC2=C1NC3=C2C=CC(=C3)OC | |
| TCMBANKIN031080 | tetrahydroharmol | C12H14N2O | 202.25 g/mol | CC1C2=C(CCN1)C3=C(N2)C=C(C=C3)O | |
| TCMBANKIN032476 | vasicoline | C19H21N3 | 291.4 g/mol | CN(C)C1=CC=CC=C1C2CCN3C2=NC4=CC=CC=C4C3 | |
| TCMBANKIN035569 | harmalol | C12H12N2O | 200.24 | CC1=NCCC2=C1NC3=C2C=CC(=C3)O | |
| TCMBANKIN035964 | harmol | C12H10N2O | 198.22 g/mol | CC1=C2C(=C3C=CC(=O)C=C3N2)C=CN1 | |
| TCMBANKIN058633 | peganine | vasicine | C11H12N2O | 188.23 | C1CN2CC3=CC=CC=C3N=C2C1O |
| TCMBANKIN059352 | lanosterol | LAN; (3beta)-lanosta-8,24-dien-3-ol; L5768_SIGMA; ZINC03870056; ST5309405; CHEBI:16521; Lanosta-8,24-dienol; 79-63-0; LMST01010017; (3S,5R,10S,13R,14R,17R)-17-[(1R)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; lanosta-8,24-dien-3beta-ol; (3beta,5alpha)-4,4,14-trimethylcholesta-8,24-dien-3-ol; Botalan base 138; (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; Lanosta-8,24-dien-3-ol, (3.beta.)-; 4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol; 8,24-Lanostadien-3beta-ol; L1504_SIGMA; Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-; Lanster; C01724; NSC60677; LANOSTEROL; Lanosterin; 3beta-Hydroxy-8,24-lanostadiene; Lanosta-8,24-dien-3.beta.-ol | C30H50O | 426.72 g/mol | CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C |
| TCMBANKIN060060 | harmine | C13H12N2O | 212.25 | CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab